Translating knowledge

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Oxytocin

OXYTOCINTM

1958
Remestyp

TERLIPRESINTM

1965
Dermazulen

DERMAZULENTM

1969
Minirin

DESMOPRESINTM

1970
Usal

USALTM

1975
Adiuretin

ADIURETINTM

1975
Duvira gel

DUVIRA GELTM

1980
Duratocin

DURATOCINTM

1985
Vistide

VISTIDETM

1996

VIREADTM

2001

HEPSERATM

2002

TRUVADATM

2004

ATRIPLATM

2006

COMPLERATM

2011

STRIBILDTM

2012

Projects & Opportunities

Here you can explore our projects which are available for co-development or licensings.

About IOCB Tech

The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.

An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.

IOCB Team

News

02/23
2018

IOCB Tech at BioVaria 2018

02/23/2018
IOCB Tech is again one of the partners at the BioVaria conference. The event will take place April 23-24, 2018, in Munich, Germany BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. In…
01/11
2018

Featured Projects

01/11/2018
Three featured projects with self-explanatory videos. Please follow the link and like always if you would like to learn more about the projects and/or IOCB-TTO please don’t hesitate to contact us via email or phone. DIANA iBodies www.ibodies.eu rapid DNA staining…

Where to meet us?